Condition: Enlarged Prostate (BPH) · Benign Prostatic Hyperplasia · Sponsor: Northwestern University
The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.
This description comes directly from the study's public registry record.
Alyssa McDonald, MPH · 312-695-8146 · alyssa.mcdonald@northwestern.edu
Always discuss trial participation with your own doctor first.
| Northwestern University | Chicago, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07632742